Amid concerns over where the UK’s coronavirus mutations could begin, the Centers for Disease Control and Prevention (CDC) said the ongoing voyage has increased the likelihood of the virus being imported to the US coast, as others wonder if the new strain How will affect. Vaccines.
In the CDC’s scientific summary, “Ongoing travel between the United Kingdom and the United States, as well as the UK’s current high prevalence of this type of ale, increases the likelihood of imports.” “A small portion of the U.S. infections are sequential, given the variable already found in the United States.
The CDC said the U.S. The variant could not be identified by sequencing in, he added, adding that “although the viruses have been created out of approximately 51,000 of the approximately 17 million U.S. cases, respectively.”
Live updates: Today’s latest COVID-19 headlines
This fact is echoed by the recent remarks of Jeremy Luban, a top virologist at the University of Massachusetts Medical School, when he told the Washington Post: [the mutated strain] Could very well be here. It can also start from here. U.S. The order in is very scattered. “
The Federal Health Agency said London accounted for 60% of recent infections, although the predominance of stress did not indicate it was more contagious.
The CDC further said, “Scientists are working to learn more about this type to better understand how easily the virus can be transmitted and whether an currently authorized vaccine will protect people from it.” “At this time, there is no evidence that this type causes a more serious illness or increases the risk of death.”
While scientists are studying the variable, the recently authorized Pfizer-Bioentech vaccine continues its rollout in the UK, and on Monday Prime Minister Boris Jones announced that more than 500,000 doses have been given.
A spokesman for Pfizer told Fox News that the company has chosen the mRNA platform for the now-authorized vaccine because of the ease with which it is transmitted through technology, in conjunction with Bioentech.
“This flexibility includes the ability to modify the RNA sequence in the vaccine to cover new strains of the virus, if one wants to exit, which is not well covered by the current vaccine,” reads an email statement. “Pfizer and Bioentech have tested the sera of people vaccinated with BNT 162B2 [COVID-19] Vaccine for its ability to neutralize multiple mutant strains. “
Get the Fox News app
“To date, we have received consistent coverage of all the strains tested. Both companies are now producing data on how well Serra can neutralize new strains from the UK with people with BNT 162B2.”
Moderna did not immediately respond to a request for comment, although Modrna’s vaccine did not appear to allow an emergency in the UK.
C.R.C. The COVID-19 disease-causing virus, according to the report, receives a new mutation in its genome every two weeks, adding that many of the mutations are not “silent” (no structural changes in the encoded protein). Other mutations can alter the components of the protein, called amino acids, but this does not affect the function of the protein.
Transformed stress in the UK involves 14 changes, among other changes.
Despite being a different kind of term in South Africa, the CDC says the transformational stress “emerged completely independently of the UK stress and is not related to it.”
